NewGenIvf (NIVF) EBT Margin (2024 - 2025)

NewGenIvf (NIVF) posted quarterly EBT Margin of 541.73% for Q4 2025, down 49912.0% YoY from N/an in Q4 2024, and down 141.48% sequentially from 1306.14% in Q3 2025.

NewGenIvf (NIVF) EBT Margin (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed EBT Margin across 2 years of filings, most recently posting 541.73% for Q4 2025.

  • In Q4 2025, EBT Margin fell 49912.0% year-over-year to 541.73%; the TTM figure through Dec 2025 stood at 155.09% (changed N/A YoY), while the FY2025 annual figure was 205.84%, up 22352.0% from the prior year.
  • EBT Margin slipped to 541.73% in Q4 2025, from 1306.14% in the prior quarter.
  • Over the last five years, EBT Margin for NIVF reached as high as 1306.14% in Q3 2025 and fell as low as 541.73% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 11.97%
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 13.51%
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 21.09%
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 9.99%
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 18.20%
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 9.26%
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 10.44%
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 8.01%
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn 557.85%
10 NewGenIvf 25,304.95 -1.41 Mn 524,025.00 -541.73%

Historic Data

Download Data
DateValue
Dec 31, 2025 -541.73%
Sep 30, 2025 1,306.14%
Dec 31, 2024 -42.61%
Sep 30, 2024 -2.06%